Row:	February 2,
2019
,
	February 3,
2018
Row:ASSETS
		Row:CURRENT ASSETS
		Row:Cash and cash equivalents 	$ 4,355 	$ 31,326
Row:Restricted cash 	4,126 	1,505
Row:Accounts receivable 	5,383 	4,469
Row:Merchandise inventory 	94,842 	109,112
Row:Prepaid expenses and other current assets 	6,657 	6,976
Row:Total current assets 	115,363 	153,388
Row:Restricted cash 	5,745 	10,675
Row:Fixed assets, , net 	7,529 	13,546
Row:Goodwill 	— 	39,191
Row:Intangible assets, net 	3,668 	23,967
Row:Other assets 	5,708 	7,139
Row:TOTAL ASSETS 	$ 138,013 	$ 247,906
Row:LIABILITIES
		Row:CURRENT LIABILITIES
		Row:Accounts payable 	$ 34,329 	$ 41,780
Row:Accrued expenses and other current liabilities 	8,132 	10,846
Row:Deferred revenue 	6,955 	7,935
Row:Total current liabilities 	49,416 	60,561
Row:Other long-term liabilities 	24,867 	29,131
Row:TOTAL LIABILITIES 	74,283 	89,692
Row:SHAREHOLDERS’ EQUITY
Preferred stock ($0.01 par value; 5,000,000 shares authorized; none issued) Common stock ($0.01 par ; value; ; 200,000,000 shares ; authorized; 64,436,671 shares and 64,305,171 shares
	— 	—
Row:issued, respectively) 	644 	643
Row:Additional paid-in capital 	344,214 	341,103
Row:Treasury stock at cost (28,177,832 and 28,156,601 shares, respectively) 	(230,166) 	(230,145)
Row:Accumulated other comprehensive loss 	(735) 	(998)
Row:(Accumulated deficit) Retained earnings 	(50,227) 	47,611
Row:TOTAL SHAREHOLDERS’ EQUITY 	63,730 	158,214
Row:TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY 	$ 138,013 	$ 247,906
Row:See Accompanying Notes to Consolidated Financial Statements.
		Row:41
		Row:February 2,
,
		February 3,
Row:2019
		2018
Row:4,355 	$ 	31,326
Row:4,126 		1,505
Row:5,383 		4,469
Row:94,842 		109,112
Row:6,657 115,363 		6,976
153,388
Row:5,745 		10,675
Row:7,529 		13,546
Row:— 		39,191
Row:3,668 		23,967
Row:5,708 		7,139
Row:138,013 	$ 	247,906
Row:$ 34,329 	$ 	41,780
Row:8,132 		10,846
Row:6,955 		7,935
Row:49,416 		60,561
Row:24,867 		29,131
Row:74,283 		89,692
Row:Common stock ($0.01 par value; issued, respectively) ; 200,000,000 shares authorized; 64,436,671 shares and 64,305,171 shares
	644 	643
Row:Additional paid-in capital 	344,214 	341,103
Row:Treasury stock at cost (28,177,832 and 28,156,601 shares, respectively) 	(230,166) 	(230,145)
Row:Accumulated other comprehensive loss 	(735) 	(998)
Row:(Accumulated deficit) Retained earnings 	(50,227) 	47,611
Row:TOTAL SHAREHOLDERS’ EQUITY 	63,730 	158,214
Row:TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY 	$ 138,013 	$ 247,906
Row:February 2,
	February 3,
Row:2019
	2018
Row:$ 412,997 $ 	437,173
Row:5,193 	5,683
Row:418,190 	442,856
Row:290,116 	299,013
Row:128,074 	143,843
Row:165,222 	167,924
Row:— 	(1,787)
Row:59,658 	29,107
Row:(96,806) 	(51,401)
Row:723 	332
Row:(227) 	(8,881)
Row:(97,302) 	(42,852)
Row:80 	(299)
Row:$ (97,382) )
$ 	(42,553)
Row:$ (2.68) $ 	(1.18)
Row:Net sales 	$ Row:Other revenue 	Row:Total revenue 	Row:Cost of sales 	Row:Gross profit 	Row:Selling, general and administrative expenses 	Row:Income from joint venture Asset impairment charges 	Row:Loss from operations 	Row:Interest expense 	Row:Other income 	Row:Loss before income taxes 	Row:Income tax expense (benefit) 	Row:Net loss 	$ Row:Basic and diluted loss per share 	$ Row:See Accompanying Notes to Consolidated Financial Statements.
	Row:42
	Row:Net loss 	$ 	(97,382) 	$ (42,553)
Row:Pension actuarial income (loss) adjustment 		263 	(196)
Row:Comprehensive loss 	$ 	(97,119) 	$ (42,749)
Row:See Accompanying Notes to Consolidated Financial Statements.
			Row:	43
		Row:	Common
Shares
Common
Stock
Additional
Paid-in
Capital
	Treasury
Shares
	Treasury
Stock
At Cost
	Other
Comprehensive
Loss
	Earnings
(Accumulaed
Deficit)
	Shareholders’
Equity
Row:Balance as of January 28,
2017 	64,253 $ 643 $ 338,075 	(28,137) 	$(230,144) 	$ (802) 	$ 90,164 $ 	197,936
Row:Net Loss 	— — — 	— 	— 	— 	(42,553) 	(42,553)
Row:Pension actuarial loss
						Row:adjustment 	— — — 	— 	— 	(196) 	— 	(196)
Row:Vested restricted shares 	50 — (39) 	(20) 	(1) 	— 	— 	(40)
Row:Common stock issued in the
						Row:acquisition of etailz 	2 — — 	— 	— 	— 	— 	—
Row:Amortization of unearned
						Row:compensation/restricted
stock amortization 	— — 3,067 	— 	— 	— 	— 	3,067
Row:Balance as of February 3,
2018 ,
	64,305 $ 643 $ 341,103 	(28,157) 	$(230,145) 	$ (998) 	$ 47,611 $ 	158,214
Row:Decrease to opening
balance of Retained
Earnings as a result of
						Row:applying ASU 2014-09 	— — — 	— 	— 	— 	(456) 	(456)
Row:Net Loss 	— — — 	— 	— 	— 	(97,382) 	(97,382)
Row:Pension actuarial income
						Row:adjustment 	— — — 	— 	— 	263 	— 	263
Row:Vested restricted shares 	— — — 	(21) 	(21) 	— 	— 	(21)
Row:Common stock issued-new
grants 	132 1 79 	— 	— 	— 	— 	80
Row:Amortization of unearned
compensation/restricted
stock amortization 	— — 3,032 	— 	— 	— 	— 	3,032
Row:Balance as of February 2,
2019 	64,437 $ 644 $ 344,214 	$(28,178) 	$(230,166) 	$ (735) 	$ (50,227) $ 	63,730
Row:See Accompanying Notes to 	Consolidated Financial Statements.
					Row:	February 2,
2019
	February 3,
2018
Row:OPERATING ACTIVITIES:
		Row:Net loss 	($ 97,382) 	($ 42,553)
Row:Adjustments to reconcile net loss to net cash used in operating activities:
		Row:Depreciation of fixed assets 	5,226 	10,272
Row:Amortization of intangible assets 	3,890 	3,890
Row:Amortization of lease valuations 	— 	(20)
Row:Stock based compensation 	3,032 	3,067
Row:Treasury stock received for payment of withholding tax on exercises of RSUs 	(21) 	—
Row:Adjustment to contingent consideration 	(272) 	(3,280)
Row:Loss on disposal of fixed assets 	422 	579
Row:Loss on impairment of goodwill and long lived assets 	59,658 	29,107
Row:Change in cash surrender value 	78 	(399)
Row:Gain on life insurance asset Changes in operating assets and liabilities that provide (use) cash:
	— 	(8,733)
Row:Accounts receivable 	(914) 	2,616
Row:Merchandise inventory 	14,535 	16,892
Row:Prepaid expenses and other current assets 	319 	1,295
Row:Other long-term assets 	6 	(668)
Row:Accounts payable 	(7,451) 	(10,527)
Row:Accrued expenses and other current liabilities 	(1,134) 	1,648
Row:Deferred revenue 	(1,509) 	(1,293)
Row:Other long-term liabilities 	(4,001) 	(1,906)
Row:Net cash used in operating activities 	(25,518) 	(13)
Row:INVESTING ACTIVITIES:
		Row:Purchases of fixed assets 	(3,689) 	(8,407)
Row:Proceeds from company owned life insurance 	— 	14,363
Row:Investment in joint venture 	— 	(2,575)
Row:Capital distributions from joint venture 	1,347 	1,101
Row:Net cash (used in) provided by investing activities 	(2,342) 	4,482
Row:FINANCING ACTIVITIES:
Exercise of equity awards, net of treasury shares received 	80 	—
Row:Vesting of long term equity awards 	— 	(39)
Row:Payments of long term borrowings 	(35,734) 	(11,657)
Row:Proceeds from long term borrowings 	35,734 	11,657
Row:Payments to etailz shareholders 	(1,500) 	(5,000)
Row:Purchase of treasury stock 	— 	(1)
Row:Net cash used in financing activities 	(1,420) 	(5,040)
Row:Net decrease in cash, cash equivalents, and restricted cash 	(29,280) 	(571)
Row:Cash, cash equivalents, and restricted cash, beginning of year 	43,506 	44,077
Row:Cash, cash equivalents, and restricted cash, end of year 	$ 14,226 	$ 43,506
Row:Supplemental disclosures and non-cash investing and financing activities:
		Row:Interest paid 	$ 723 	$ 332
Row:Issuance of restricted performance based awards / deferred / restricted shares under deferred / restricted
		Row:stock agreements 	109 	120
Row:See Accompanying Notes to Consolidated Financial Statements.
45
		